[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100404318":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":10,"centralContacts":26,"locations":36,"responsibleParty":73,"collaborators":75,"id":78,"slug":10,"hasResults":79,"nctId":80,"briefTitle":81,"officialTitle":82,"acronym":10,"eligibilityCriteria":83,"healthyVolunteers":79,"sex":84,"minAge":85,"maxAge":86,"enrollmentInfo":87,"targetDuration":90,"studyType":91,"phases":10,"briefSummary":92,"conditions":93,"keywords":10,"overallStatus":39,"whyStopped":10,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":101,"completionDateStruct":103,"leadSponsor":105,"locationsCount":106},{"fullName":5,"class":6},"Universitaire Ziekenhuizen KU Leuven","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Allergic rhinitis patients",null,"Patients with persistent or intermittent allergic rhinitis complaints, confirmed by skin prick tests and\u002For immunocap for specific IgEs, that start with AIT treatment.",[13,14],"Drug: AIT","Diagnostic Test: NAPT",[16,21],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":10},"DRUG","AIT","AIT for airborn allergens (SCIT\u002FSLIT)",[9],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":10},"DIAGNOSTIC_TEST","NAPT","NAPT test with airborn allergens ( HDM, Threes, Grasses)",[9],[27,32],{"name":28,"role":29,"phone":30,"phoneExt":10,"email":31},"Margot Vandekerckhove","CONTACT","+3216332342","margot.vandekerckhove@uzleuven.be",{"name":33,"role":29,"phone":34,"phoneExt":10,"email":35},"Laura Van Gerven, PhD","+3216336340","laura.vangerven@uzleuven.be",[37,58],{"facility":38,"status":39,"city":40,"state":41,"zip":42,"country":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"UZ Leuven","RECRUITING","Leuven","Vlaam Brabant","3000","Belgium",{"type":45,"coordinates":46},"Point",[47,48],4.70093,50.87959,{"lat":48,"lon":47},[51,52,55],{"name":28,"role":29,"phone":30,"phoneExt":30,"email":31},{"name":53,"role":29,"phone":54,"phoneExt":34,"email":35},"Laura Van Gerven","+3216336390",{"name":56,"role":57,"phone":10,"phoneExt":10,"email":10},"Laura Van Gerven, MD, PhD","PRINCIPAL_INVESTIGATOR",{"facility":59,"status":60,"city":61,"state":10,"zip":62,"country":43,"cosmosGeoPoint":63,"geoPoint":67,"contacts":68},"AZ Sint-Jan","NOT_YET_RECRUITING","Bruges","8000",{"type":45,"coordinates":64},[65,66],3.22424,51.20892,{"lat":66,"lon":65},[69],{"name":70,"role":29,"phone":71,"phoneExt":10,"email":72},"Kato Speleman, MD","050452280","nok@azsintjan.be",{"type":57,"investigatorFullName":53,"investigatorTitle":74,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"prof. dr. Laura Van Gerven",[76],{"name":77,"class":6},"AZ Sint-Jan AV","100404318",false,"NCT04544774","The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy","The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy: An Academic Multicentre Clinical Study","Inclusion Criteria:\n\n* Age \\>18 and ≤60 years\n* Persistent or intermittent allergic rhinitis complaints, confirmed by SPT and\u002Fof immunocap for the specific IgEs.\n\nOR suspected local allergic rhinitis\n\n* Patients who start with AIT treatment\n* The patient must be motivated and willing to come to all visits\n* The patient must be able to understand and sign the informed consent\n\nExclusion Criteria:\n\n* Uncontrolled asthma\n* Conditions affecting the functioning of the immune system (eg: immune deficiencies, malignancies, autoimmune diseases)\n* Use of β-blockers, immunosuppressants or ACE inhibitors\n* Hypersensitivity to aluminum hydroxide and\u002For hypersensitivity to any of the excipients in AIT\n* Anaphylaxis after allergen challenge in the past\n* Acute rhinosinusitis in the last 12 weeks\n* Recent surgery on the nose and\u002For paranasal sinuses in the last 12 weeks\n* Pregnancy","ALL","18 Years","60 Years",{"count":88,"type":89},200,"ESTIMATED","3 Years","OBSERVATIONAL","This prospective multicentric academic NAPT study aims to compile a database of all patients who initiate immunotherapy.\n\nThe NAPT will take place before, during and after AIT to evaluate the cost and effectiveness of the treatment. The study consists of 4 visits and 2 telephone contacts that are repeated annually for 3 years.\n\nThis study will be conducted in 2 hospitals: UZ Leuven and AZ ST. Jan Brugge on the consultation Ear, Nose and Throat Diseases (ENT) and the department of Internal Medicine \u002F Allergology",[94,95,96],"Perennial Allergic Rhinitis","Seasonal Allergic Rhinitis","Local Allergic Rhinitis","2026-04-30",{"date":99,"type":100},"2026-05-01","ACTUAL",{"date":102,"type":100},"2020-07-16",{"date":104,"type":89},"2026-12",{"name":5,"class":6},2]